Table 1

Affinities of S33005 as compared with reference antidepressant agents at monoamine transporters and at monoaminergic receptors known to modulate cerebral monoaminergic transmission

SpeciesRadioligand (nM)TissueS33005VenlafaxineClomipramineCitalopramReboxetine
SERTRat[3H]Paroxetine (2)Frontal cortex8.71  ± 0.067.61  ± 0.068.92  ± 0.238.82  ± 0.036.79  ± 0.19
(1.9)(24.5)(1.2)(1.5)(162)
SERTHuman[3H]Paroxetine (2)HEK293 cell line8.67  ± 0.187.12  ± 0.059.86  ± 0.118.33  ± 0.256.97  ± 0.22
(2.1)(75.9)(0.14)(4.7)(107)
NETRat[3H]Nisoxetine (2)Frontal cortex6.75  ± 0.116.00  ± 0.097.57  ± 0.095.42  ± 0.058.28  ± 0.18
(178)(1000)(26.9)(3800)(5.2)
NETHuman[3H]Nisoxetine (2)MDCK cell line5.82  ± 0.095.20  ± 0.107.27  ± 0.08<57.80  ± 0.04
(1510)(6310)(53.7)(15.8)
DATRat[3H]GR12935 (2)Striatum<5<55.91  ± 0.31<5<5
(1230)
DATHuman[3H]GR12935 (2)CHO cell line<5<55.52  ± 0.02<5<5
(3020)
5-HT1A Human[3H]8-OH-DPAT (0.4)CHO cell line<5<5<5<5<5
5-HT1B Human[3H]GR125,743 (1.0)CHO cell line<5<5<5<5<5
5-HT1D Human[3H]GR125,743 (1.0)CHO cell line<5<5<5<5<5
5-HT2A Human[3H]Ketanserin (0.5)CHO cell line<5<57.45  ± 0.10<5<5
(35.5)
5-HT2C Human[3H]Mesulergine (1.0)CHO cell line<5<57.19  ± 0.116.21  ± 0.126.34  ± 0.07
(64.6)(617)(457)
5-HT3 Mouse[3H]BRL43694 (1.0)NE-15 cell line<5<56.07  ± 0.17<5<5
(85.1)
α1-ARRat[3H]Prazosin (0.2)Frontal cortex<5<57.81  ± 0.18<5<5
(15.5)
1A-ARHuman[3H]Prazosin (0.1)CHO cell line<5<58.49  ± 0.10<5<5
(3.2)
α2-ARRat[3H]RX821,002 (0.40)Cortex<5<5<5<5<5
α2A-ARHuman[3H]RX821,002 (0.4)CHO cell line<5<56.28  ± 0.281-a <5<5
(525)
D2 Human[3H]Spiperone (0.1)CHO cell line<5<57.11  ± 0.091-a <5<5
(77.6)
D3 Human[3H]Spiperone (0.3)CHO cell line<5<57.30  ± 0.091-a <5<5
(50.1)
  • MDCK, Madin-Darby canine kidney cells.

  • Data are presented as mean ± S.E.M. pKi of 3 to 4, or

  • 1-a  means ± range of two independent determinations, each performed in triplicate. In addition, equivalent Ki values are indicated in parentheses: a pKi of <5 corresponds to a Ki of >10,000 nM.